<?xml version="1.0" ?>
<document id="6d077aec25d3730a6037bf89f1fb73286846fb64">
  <chunk id="6d077aec25d3730a6037bf89f1fb73286846fb64.c0" text="molecules Saponins from Chinese Medicines as Anticancer Agents"/>
  <chunk id="6d077aec25d3730a6037bf89f1fb73286846fb64.c1" text="Saponins are glycosides with triterpenoid or spirostane aglycones that demonstrate various pharmacological effects against mammalian diseases. To promote the research and development of anticancer agents from saponins, this review focuses on the anticancer properties of several typical naturally derived triterpenoid saponins (ginsenosides and saikosaponins) and steroid saponins (dioscin, polyphyllin, and timosaponin) isolated from Chinese medicines. These saponins exhibit in vitro and in vivo anticancer effects, such as anti-proliferation, anti-metastasis, anti-angiogenesis, anti-multidrug resistance, and autophagy regulation actions. In addition, related signaling pathways and target proteins involved in the anticancer effects of saponins are also summarized in this work. of the saponins ginsenoside, saikosaponin, dioscin, polyphyllin, and timosaponin. This work will hopefully serve as a reference for further development of saponins as anticancer agents.">
    <entity charOffset="613-622" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c1.e0" ontology_id="GO_0006914" text="autophagy" type="gene_function"/>
    <entity charOffset="664-673" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c1.e1" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
  </chunk>
  <chunk id="6d077aec25d3730a6037bf89f1fb73286846fb64.c2" text="Triterpenoid Saponins"/>
  <chunk id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3" text="Ginsenosides are the main active components of Ginseng radix (Renshen in Chinese), which is widespread in northeast China, Korea, and Japan. It has been used in Asian countries for centuries to treat various diseases because of its wide spectrum of pharmacological effects [13] . Additionally, ginsenosides are also found in American ginseng (Xiyangshen in Chinese). More than 100 ginsenosides have been isolated from Ginseng radix and are classified into protopanaxadiol (PPD), protopanaxatriol (PPT), ocotillol, and oleanolic acid types. The main structural difference between the PPD and PPT types is the presence of sugar residues attached to an α-OH at C-6 and the absence of β-OH at C-3 in the PPT moiety [14] . These compounds have recently received increasing attention due to their anticancer properties. Compared with the PPT-type ginsenosides, the PPD-type ginsenosides exhibit stronger anticancer potentials. Ginsenoside Rg3 ( Figure 1a ) and Rh2 (Figure 1b) are the most well-studied active PPD-type anticancer congeners. Other PPD-type ginsenosides, such as ginsenoside Rb1 [15], Rb2 [16], Rc [17], Rd [18], and Rk1 [19], as well as PPT-type ginsenosides such as Re [20] and Rf [21] have also demonstrated anticancer activities with similar mechanisms as those in ginsenoside Rg3 or Rh2. 2.1.1. Ginsenoside Rg3 Ginsenoside Rg3 demonstrates therapeutic effects in vitro and/or in vivo against various tumors, including leukemia [22], lung cancer [23], esophageal carcinoma [24], gastric cancer [25], colon cancer [26-28], hepatoma [29,30], renal cancer [31], bladder cancer [32], breast cancer [33], ovarian cancer [34], prostate cancer [35,36] and melanoma [37-39]. Moreover, combination therapy of ginsenoside Rg3 with other chemotherapeutic agents has also become the focus of recent research. Ginsenoside Rg3 reinforces the anticancer effects when combined with cyclophosphamide [40-42], capecitabine [43], docetaxel [26,35], gemcitabine [44], cisplatin [32,45], doxorubicin [46], verapamil [47]">
    <entity charOffset="1432-1440" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e0" ontology_id="HP_0001909" text="leukemia" type="phenotype"/>
    <entity charOffset="1452-1458" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e1" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1465-1485" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e2" ontology_id="HP_0011459" text="esophageal carcinoma" type="phenotype"/>
    <entity charOffset="1476-1485" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e3" ontology_id="HP_0030731" text="carcinoma" type="phenotype"/>
    <entity charOffset="1492-1506" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e4" ontology_id="HP_0012126" text="gastric cancer" type="phenotype"/>
    <entity charOffset="1500-1506" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e5" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1513-1525" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e6" ontology_id="HP_0003003" text="colon cancer" type="phenotype"/>
    <entity charOffset="1519-1525" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e7" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1559-1565" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e8" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1572-1586" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e9" ontology_id="HP_0009725" text="bladder cancer" type="phenotype"/>
    <entity charOffset="1580-1586" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e10" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1593-1606" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e11" ontology_id="HP_0003002" text="breast cancer" type="phenotype"/>
    <entity charOffset="1600-1606" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e12" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1621-1627" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e13" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1634-1649" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e14" ontology_id="HP_0012125" text="prostate cancer" type="phenotype"/>
    <entity charOffset="1643-1649" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e15" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="1662-1670" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c3.e16" ontology_id="HP_0002861" text="melanoma" type="phenotype"/>
  </chunk>
  <chunk id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4" text=", and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [48] . Additionally, ginsenoside Rg3 sensitizes cancer cells to γ-radiation by targeting the nuclear factor-kappa B (NF-κB) pathway [49], vascular endothelial growth factor (VEGF), and HIF-1α [34, 50] . In vivo studies have suggested that ginsenoside Rg3 not only reduces tumor growth, but also enhances cellular immunity [51], prolongs the survival time, and improves the quality of life of mice with tumors [41]. Ginsenoside Rg3 treatment affects a broad range of signaling pathways and factors, including downregulation or deactivation of epidermal growth factor receptor (EGFR) [52,53], inactivation of NF-κB by reducing phosphorylation of extracellular signal-regulated kinases (ERK) and protein kinase B (AKT) [54], suppression of NF-κB/p65 signaling pathway [37], modulation of mitogen-activated protein kinases (MAPK) [36], down-regulation of Wnt/β-catenin signaling [27], inhibition of CXC receptor 4 (CXCR4) [55], down-regulation of AQP1 expression through p38 pathway [56], down-regulation of phosphatidylinositol 3-kinase (PI3K)/AKT family proteins and inhibitor of apoptosis protein (IAP) family proteins [22,57], reduction of histone deacetylase 3 expression and enhancement of p53 acetylation [39], inhibition of autophagy [46], suppression of anoikis resistance [58], and suppression of Warburg effect through signal transducer and activator of transcription 3 (STAT3)/HK2 pathway [59]">
    <entity charOffset="6-11" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" ontology_id="HP_0002664" text="tumor" type="phenotype"/>
    <entity charOffset="12-20" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e1" ontology_id="GO_0001906" text="necrosis" type="gene_function"/>
    <entity charOffset="118-124" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="229-235" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e3" ontology_id="GO_0040007" text="growth" type="gene_function"/>
    <entity charOffset="342-347" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" ontology_id="HP_0002664" text="tumor" type="phenotype"/>
    <entity charOffset="348-354" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e5" ontology_id="GO_0040007" text="growth" type="gene_function"/>
    <entity charOffset="536-545" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e6" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="622-628" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e7" ontology_id="GO_0040007" text="growth" type="gene_function"/>
    <entity charOffset="646-650" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e8" ontology_id="GO_0005006" text="EGFR" type="gene_function"/>
    <entity charOffset="695-710" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e9" ontology_id="GO_0016310" text="phosphorylation" type="gene_function"/>
    <entity charOffset="714-727" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e10" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="754-757" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e11" ontology_id="GO_0004707" text="ERK" type="gene_function"/>
    <entity charOffset="817-826" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e12" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="817-834" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e13" ontology_id="GO_0007165" text="signaling pathway" type="gene_function"/>
    <entity charOffset="890-894" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e14" ontology_id="GO_0004707" text="MAPK" type="gene_function"/>
    <entity charOffset="935-944" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e15" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="1298-1307" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e16" ontology_id="GO_0006914" text="autophagy" type="gene_function"/>
    <entity charOffset="1329-1336" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e17" ontology_id="GO_0043276" text="anoikis" type="gene_function"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e1" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p0" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e3" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p1" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e5" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p2" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e6" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p3" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e7" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p4" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e8" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p5" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e9" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p6" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e10" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p7" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e11" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p8" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e12" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p9" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e13" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p10" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e14" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p11" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e15" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p12" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e16" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p13" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e17" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p14" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e1" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p15" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e1" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p16" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e3" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p17" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e5" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p18" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e6" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p19" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e7" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p20" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e8" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p21" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e9" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p22" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e10" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p23" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e11" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p24" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e12" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p25" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e13" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p26" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e14" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p27" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e15" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p28" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e16" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p29" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e2" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e17" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p30" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e3" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p31" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e5" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p32" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e6" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p33" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e7" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p34" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e8" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p35" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e9" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p36" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e10" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p37" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e11" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p38" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e12" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p39" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e13" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p40" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e14" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p41" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e15" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p42" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e16" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p43" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e4" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.e17" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c4.p44" relation="true"/>
  </chunk>
  <chunk id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5" text=". Furthermore, the anticancer mechanisms of ginsenoside Rg3 is related to the alteration of Bcl-2 family proteins expression, including downregulation of Bcl-2 and Bcl-xL, upregulation or activation of Bax [29, 60] , and activation of caspase cascade [61, 62] . Another study recently found that ginsenoside Rg3 can inhibit the growth and survival of gastric cancer cells via blockade of the activity of transient receptor potential melastatin 7 channel [63], which is essential for cell survival that make it a potential target for gastric cancer treatment. Moreover, ginsenoside Rg3 also exhibits other anticancer properties, such as declination of fucosyltransferase IV">
    <entity charOffset="328-334" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e0" ontology_id="GO_0040007" text="growth" type="gene_function"/>
    <entity charOffset="351-365" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e1" ontology_id="HP_0012126" text="gastric cancer" type="phenotype"/>
    <entity charOffset="359-365" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e2" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <entity charOffset="404-413" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e3" ontology_id="HP_0025153" text="transient" type="phenotype"/>
    <entity charOffset="533-547" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e4" ontology_id="HP_0012126" text="gastric cancer" type="phenotype"/>
    <entity charOffset="541-547" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e5" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e1" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.p0" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e2" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.p1" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e3" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.p2" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e4" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.p3" relation="true"/>
    <pair e1="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e0" e2="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.e5" id="6d077aec25d3730a6037bf89f1fb73286846fb64.c5.p4" relation="true"/>
  </chunk>
</document>
